Your browser is no longer supported. Please, upgrade your browser.
Settings
ATNF [NASD]
180 Life Sciences Corp.
Index- P/E- EPS (ttm)-1.97 Insider Own17.50% Shs Outstand24.13M Perf Week-2.15%
Market Cap252.16M Forward P/E- EPS next Y- Insider Trans-1.04% Shs Float13.80M Perf Month39.89%
Income-9.30M PEG- EPS next Q- Inst Own7.30% Short Float15.81% Perf Quarter59.30%
Sales- P/S- EPS this Y-130.90% Inst Trans12.74% Short Ratio0.91 Perf Half Y337.24%
Book/sh0.91 P/B11.48 EPS next Y- ROA-76.60% Target Price- Perf Year-0.95%
Cash/sh0.02 P/C504.32 EPS next 5Y- ROE-156.80% 52W Range1.90 - 13.05 Perf YTD282.78%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-19.89% Beta-0.50
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin- 52W Low450.00% ATR0.76
Employees2 Current Ratio0.10 Sales Q/Q- Oper. Margin- RSI (14)59.06 Volatility5.54% 7.71%
OptionableYes Debt/Eq0.55 EPS Q/Q- Profit Margin- Rel Volume0.09 Prev Close10.51
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.39M Price10.45
Recom- SMA2012.64% SMA5013.90% SMA20051.86% Volume215,881 Change-0.57%
Jun-10-21 09:12AM  
Jun-01-21 08:00AM  
May-28-21 08:00AM  
May-21-21 04:45PM  
Apr-20-21 08:00AM  
Apr-19-21 05:00PM  
Apr-14-21 08:15AM  
Mar-26-21 08:30AM  
Mar-25-21 08:30AM  
Mar-24-21 08:30AM  
Mar-08-21 01:30PM  
Feb-24-21 04:00PM  
Feb-19-21 09:00AM  
Feb-17-21 12:00AM  
Jan-11-21 08:00AM  
Jan-05-21 02:50PM  
Dec-03-20 11:08AM  
Nov-24-20 10:00AM  
Nov-23-20 08:30AM  
Nov-17-20 08:00AM  
Nov-10-20 11:46AM  
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KRAUSS MARLENE10% OwnerDec 17Sale2.4816,50640,8802,006,858Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerDec 15Sale2.4017,87742,9052,543,676Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerDec 14Sale2.4510,00024,5002,561,553Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerNov 25Sale2.7812,18233,8092,571,556Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 23Sale3.2660,633197,6762,583,738Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 19Sale2.1233,44570,8372,644,371Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 18Sale2.316,70015,4802,677,816Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 17Sale2.263,3007,4452,684,516Dec 01 07:00 PM